REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,919 | +15.7% | 345,386 | +2.9% | 0.17% | +14.3% |
| Q2 2023 | $47,474 | +27.2% | 335,599 | +51.3% | 0.15% | +14.0% |
| Q1 2023 | $37,333 | +29.6% | 221,745 | +30.3% | 0.13% | +25.2% |
| Q4 2022 | $28,817 | -99.9% | 170,205 | +6.9% | 0.10% | -12.0% |
| Q3 2022 | $29,783,000 | +9.8% | 159,177 | -4.7% | 0.12% | +13.6% |
| Q2 2022 | $27,123,000 | -8.3% | 167,013 | +6.2% | 0.10% | 0.0% |
| Q1 2022 | $29,570,000 | -34.9% | 157,211 | -8.3% | 0.10% | -32.2% |
| Q4 2021 | $45,403,000 | +10.1% | 171,436 | +20.2% | 0.15% | -0.7% |
| Q3 2021 | $41,220,000 | +39.4% | 142,635 | -3.7% | 0.15% | +45.7% |
| Q2 2021 | $29,576,000 | +31.8% | 148,160 | +28.3% | 0.10% | +12.9% |
| Q1 2021 | $22,444,000 | +128.7% | 115,447 | +1.1% | 0.09% | +16.2% |
| Q2 2019 | $9,815,000 | +18.0% | 114,191 | -18.9% | 0.08% | +14.3% |
| Q1 2019 | $8,320,000 | +22.5% | 140,833 | +6.4% | 0.07% | +11.1% |
| Q4 2018 | $6,791,000 | -19.2% | 132,304 | -12.7% | 0.06% | -3.1% |
| Q3 2018 | $8,409,000 | -49.7% | 151,624 | -57.3% | 0.06% | -53.6% |
| Q2 2018 | $16,718,000 | +38.8% | 355,397 | +6.8% | 0.14% | +38.6% |
| Q1 2018 | $12,042,000 | -0.1% | 332,831 | +0.2% | 0.10% | -1.9% |
| Q4 2017 | $12,054,000 | -3.1% | 332,260 | +2.3% | 0.10% | -1.9% |
| Q3 2017 | $12,445,000 | +13.4% | 324,766 | +22.6% | 0.10% | +8.2% |
| Q2 2017 | $10,975,000 | -37.2% | 264,837 | -46.6% | 0.10% | -39.4% |
| Q1 2017 | $17,474,000 | +13.5% | 496,410 | -0.6% | 0.16% | +8.1% |
| Q4 2016 | $15,394,000 | +79.3% | 499,494 | +75.6% | 0.15% | +102.7% |
| Q3 2016 | $8,586,000 | +27.3% | 284,384 | +15.4% | 0.07% | +28.1% |
| Q2 2016 | $6,743,000 | +6.8% | 246,465 | +4.7% | 0.06% | +5.6% |
| Q1 2016 | $6,315,000 | -17.0% | 235,443 | -12.5% | 0.05% | -16.9% |
| Q4 2015 | $7,612,000 | +2.0% | 269,071 | +0.4% | 0.06% | 0.0% |
| Q3 2015 | $7,463,000 | -43.1% | 267,961 | -15.7% | 0.06% | -38.7% |
| Q2 2015 | $13,114,000 | +7.4% | 317,753 | -21.0% | 0.11% | +14.0% |
| Q1 2015 | $12,216,000 | +34.5% | 402,385 | -12.3% | 0.09% | +27.4% |
| Q4 2014 | $9,083,000 | -2.3% | 458,753 | -1.7% | 0.07% | -2.7% |
| Q3 2014 | $9,295,000 | +5.6% | 466,844 | +20.9% | 0.08% | +10.3% |
| Q2 2014 | $8,800,000 | – | 386,134 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |